Investigators have found that the gene Asah1 plays a crucial protective role in preventing the progression of nonalcoholic ...
NAFLD-the silent epidemic: NAFLD, caused by excessive fat accumulation in the liver, is now the most common chronic liver ...
A fatty liver is the most common. Dr Sudeep Khanna, senior consultant, gastroenterology, Indraprastha Apollo Hospitals, ...
Rate this content's potential impact on patient outcomes Submit Rating Average rating / 5. Vote count: No votes so far! Be ...
A new study published in the journal of Nature Scientific Reports showed that the patients with hypothyroidism have increased ...
Alcoholic and non-alcoholic fatty liver disease (NAFLD) are well-known risk factors for colorectal cancer (CRC). NAFLD has ...
With the rising epidemic of obesity, metabolic syndrome, and type 2 diabetes mellitus in China, metabolic ...
March 4, 2025) - BioHarvest Sciences Inc. (NASDAQ: BHST) (FSE: 8MV0) ("BioHarvest" or "the Company"), a company pioneering its patented Botanical Synthesis technology process, today announced new 'in ...
At 2 years, participants in the compensated MASH cirrhosis treatment arm of the MAESTRO-NAFLD-1 trial experienced a ...
Recent figures show that around 63% of UK adults are either overweight or obese, and it's estimated that one in three have early-stage non-alcoholic fatty liver disease (NAFLD). NAFLD is a term ...
Madrigal Pharmaceuticals (MDGL) reported positive two-year results from the open-label compensated MASH cirrhosis arm of the Phase 3 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback